Supposedly this funding will be sufficient to start a clinical trial for AMD but HBV will have to wait. Does anyone really believe this? I am still holding out for good TT-034 results but I have to say that recent events have dented my confidence in the cohort three outcomes. Fortunately, we won't have to wait too much long to see whether there will be agony or ecstasy when efficacy is announced.
- Forums
- ASX - By Stock
- BLT
- Updated listing price
Updated listing price, page-24
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)